ClinConnect ClinConnect Logo
Search / Trial NCT06795815

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

Launched by AZIENDA USL REGGIO EMILIA - IRCCS · Jan 21, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Advance Care Planning Go Wish Game Medical Oncology Hematology Oncology Palliative Care Experimental Design Study Mixed Methods

ClinConnect Summary

This clinical trial, called "The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco-Hematologic Disease," is studying how a special card game can help patients with serious blood cancers, like leukemia and lymphoma, talk about their wishes for end-of-life care. The game, called the Go Wish Game, uses cards that list different wishes and values related to what someone might want during this time. The goal is to help patients, their families, and healthcare providers have important conversations about care preferences and complete necessary planning documents.

To participate in this trial, individuals must be at least 18 years old and diagnosed with certain types of cancer that have a prognosis of more than three months. They should also be able to communicate in Italian and give written consent to join. Throughout the study, participants will engage in the Go Wish Game, and researchers will gather feedback through interviews and questionnaires to see how well the game works in improving communication and understanding around end-of-life decisions. This trial is currently not recruiting participants, but it is designed to make discussions about care preferences easier and more effective for patients and their families.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 18 years age; diagnosed with refractory lymphomas, or leukemia or multiple myeloma or advanced solid tumors and estimated prognosis \> 3 months;
  • able to communicate in Italian and
  • to give written consent to the study.
  • Exclusion Criteria:
  • Patients with severe cognitive impairment or serious psychiatric condition;
  • refusal to participate to the study

About Azienda Usl Reggio Emilia Irccs

Azienda USL Reggio Emilia - IRCCS is a leading healthcare organization in Italy, dedicated to advancing medical research and improving patient care through innovative clinical trials. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, fostering collaboration among healthcare professionals, researchers, and academic institutions. The organization is committed to conducting rigorous, ethical studies that contribute to the advancement of medical knowledge and the development of new therapies, ensuring high standards of patient safety and welfare throughout the research process.

Locations

Reggio Emilia, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported